Newly FDA-approved DOR/ISL offers an INSTI-free, 2-drug HIV treatment option with durable suppression and favorable safety.

April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's (MRK.N), opens new tab once-daily, oral, combination regimen for HIV infections, the drugmaker ‌said on Tuesday, giving ...

The official numbers are finally here.

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.

Doctors say a Toronto man has shown no signs of his HIV infection since receiving a bone marrow transplant. If he stays virus-free through 2027, he'll be considered cured.

The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV treatment that pairs two drug classes in a single tablet. The approval gives ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and credited with saving millions of lives. How did Trump's aid cuts affect it?

Ugandan cancer specialists have warned of shifting cancer trends, reflecting a mix of declining infection-related cancers ...

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...

Poor record-keeping means authorities cannot contact thousands of patients who may have contracted HIV or hepatitis at a dental practice.